Jul. 1 at 3:32 PM
$BSX IMHO and based on the silly tools I use :-) , I think that the volume-weighted average price between 05/15/26 and 06/30/26 (the end of the ASR) is roughly
$48.35
yesterday's push down of the stock price significantly reduced that price tag.
If this is true, the
$2B ASR would buy about 41M shares of Boston Scientific. Is that how
$BSX plans to pay for the stock portion of
$PEN ?
If yes, the big question is what will be the stock price at the close of the transaction? It is obviously in the interest of the company and its shareholders to have that as high as possible....
Do your research, this is my personal opinion and not an advice to buy or sell the stock.
